Shareholders Demand Pfizer Scrap Race-Conscious Policies in the Wake of Civil Rights Lawsuit
That didn’t take long. Less than a week after Pfizer was hit with a lawsuit over a fellowship program that excludes whites and Asians, shareholders are demanding that the company scrap a spate of race-conscious policies that they say put it at risk of further litigation.
The lawsuit, filed Sept. 15, argues that Pfizer is violating federal law by excluding white and Asian applicants from its prestigious “Breakthrough Fellowship.” In an open letter to Pfizer executives last week, shareholders allege that the program is just one of several policies that invite a “pandora’s box” of civil rights complaints.
Read more on the Washington Free Beacon.
Become a Member
Help us protect patients, physicians, and healthcare itself from radical, divisive ideology.
Share Your Concern
Have you seen divisive ideology or discrimination at your healthcare employer, medical school, or medical provider? Let us know – anonymously.
Get up to speed with the threats facing healthcare – and how we’re protecting patients and physicians.
"*" indicates required fields